{
    "clinical_study": {
        "@rank": "132670", 
        "arm_group": [
            {
                "arm_group_label": "high fat ( MUFA) diet", 
                "arm_group_type": "Experimental", 
                "description": "intervention using high fat diet."
            }, 
            {
                "arm_group_label": "high carb/high fiber", 
                "arm_group_type": "Experimental", 
                "description": "diet using high carb-high fiber with dry beans"
            }, 
            {
                "arm_group_label": "high carb/low fat", 
                "arm_group_type": "Experimental", 
                "description": "Habitual diet"
            }
        ], 
        "brief_summary": {
            "textblock": "Assessment of glucose metabolism and liver fat after 12 week dietary intervention in pre\n      diabetes subjects. Subjects will be randomized to either high fat (olive oil\n      supplemented),high carb/high fiber (beans supplemented) and high carb/low fiber diets.\n      Glucose metabolism will be assessed by labeled oral glucose tolerance test and liver fat by\n      magnetic resonance spectroscopy pre randomization and at 8 and 12 week after starting\n      dietary intervention."
        }, 
        "brief_title": "Dietary Interventions in Prediabetes", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Impaired Fasting Glucose", 
            "Pre Diabetes", 
            "Liver Fat"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Glucose Intolerance", 
                "Prediabetic State"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Impaired fasting glucose(100-125 mg/dl)\n\n          -  HbA1c 5.7-6.4 %\n\n          -  BMI 26-40 kg/sq.m\n\n        Exclusion Criteria:\n\n          -  MRS contraindication\n\n          -  Pregnant women\n\n          -  Liver disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": {
            "#text": "48", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 9, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01729078", 
            "org_study_id": "12-003216"
        }, 
        "intervention": {
            "arm_group_label": [
                "high fat ( MUFA) diet", 
                "high carb/high fiber", 
                "high carb/low fat"
            ], 
            "description": "three different diets ( high fat-low carb-low fiber/high carb-low fat - high fiber/high carb-low fat-low fiber)", 
            "intervention_name": "Dietary intervention", 
            "intervention_type": "Dietary Supplement"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 24, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Rochester", 
                    "country": "United States", 
                    "state": "Minnesota", 
                    "zip": "55901"
                }, 
                "name": "Mayo clinic"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "The Effects of Dietary Supplementation on Hepatic Insulin Action and Glucose Tolerance in Pre-diabetes", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Changes in liver fat content after 12 weeks of intervention", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01729078"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Mayo Clinic", 
            "investigator_full_name": "Rita Basu", 
            "investigator_title": "PI", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Change in glucose metabolism after 12 weeks of intervention", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "source": "Mayo Clinic", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mayo Clinic", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}